Martin Kohlhäeufl

  • Citations Per Year
Learn More
Purpose Nivolumab, a programmed death-1 inhibitor, prolonged overall survival compared with docetaxel in two independent phase III studies in previously treated patients with advanced squamous(More)
  • 1